Treatment of drug‐eluting stent restenosis with the same versus different drug‐eluting stent

Abstract

Reimplantation of DES for the treatment of DES ISR (same or different) is safe but associated with a high rate of recurrences at 1 year regardless of the initial DES type. Other treatment modalities for ISR of DES should be considered to further improve the overall TVR-MACE.